Background: EUS response assessment in patients with locally advanced esophageal cancer undergoing neoadjuvant chemoradiation therapy (CRT) is limited by disintegration of the involved anatomic structures.
Objective: Predictive and prognostic values of a prospectively defined maximum tumor thickness (MTT).
Design: Prospective open-label phase ll study (SAKK 75/02).